BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28
• 31

• BioMidwest

  St. Jude Medical Release: Five Year Data From The FAME Trial Further Confirms The Sustained, Long Term Benefit Of FFR-Guided PCI Over Angiography-Guided Intervention

  August 31, 2015

   · 

  1 min read
• BioMidwest

  St. Jude Medical Release: LEADLESS II Trial Results Published In The New England Journal of Medicine Confirm The Positive Benefits Of The Nanostim Leadless Pacemaker

  August 31, 2015

   · 

  1 min read
• Pharm Country

  BeyondSpring To Present Two Posters Supporting Plinabulin At WCLC 2015

  August 31, 2015

   · 

  2 min read
• BioMidwest

  Sunshine Heart Announces FDA Approves Key Protocol Amendment For COUNTER HF US Pivotal Study For C-Pulse Heart Assist System

  August 31, 2015

   · 

  6 min read
• Business

  Daktari Enters Collaboration Agreement With Merck & Co. To Develop Test For Hepatitis C Virus

  August 31, 2015

   · 

  3 min read
• Drug Development

  Alnylam Release: ALN-PCSsc Achieves Quarterly And Potentially Bi-Annual Subcutaneous Dose Regimen Profile For Effective LDL-C Lowering In Phase 1 Clinical Study

  August 31, 2015

   · 

  1 min read
• ESC Launches New Concept For Driving Innovation In Cardiovascular Research With Exclusive Support From Boehringer Ingelheim

  August 31, 2015

   · 

  1 min read
• Business

  AMRI Announces Agreement With Saneca Pharmaceuticals, a.s. For Portfolio Of Opium-Derived Active Pharmaceutical Ingredients

  August 31, 2015

   · 

  5 min read
• Biotech Bay

  Stellar Biotechnologies, Inc. Announces Reverse Stock Split In Preparation For Proposed Uplisting To NASDAQ Capital Market

  August 31, 2015

   · 

  4 min read
• Drug Development

  Corbus Commences Patient Enrollment In Phase 2 Clinical Study Of Resunab For The Treatment Of Systemic Sclerosis

  August 31, 2015

   · 

  7 min read